Glycation of apoA-I and Diabetic Atherogenesis

计划入组 2,000 人 · 首次发布于 2022 年 12 月 21 日

Theobromine, Vascular Function and Intestinal apoA-I Production

计划入组 48 人 · 首次发布于 2014 年 8 月 5 日

The Effects of Fat and Theobromine on apoA-I

计划入组 10 人 · 首次发布于 2014 年 3 月 12 日

5A apoA-I mimetic peptide

4-WF

1-CD20 single chain variable antibody-apolipoprotein-A1 fusion protein (Abionyx)

Universitetet i Oslo

Norway

I-SHOU UNIVERSITY

Taiwan

i-SENS, Inc.

South Korea

ApoA-I Infusions Show Promise in Reducing Cardiovascular Events Post-MI, Especially in Patients with Lower LDL-C

ABIONYX Secures Up to €33M and Launches Pivotal Phase 2b Trial of CER-001 in Sepsis

EMA Provides Positive Feedback on ABIONYX Pharma's CER-001 for LCAT Deficiency